# A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

> **NCT00936988** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 45 (actual)

## Conditions studied

- Hyperparathyroidism, Primary

## Interventions

- **DRUG:** cinacalcet

## Key facts

- **NCT ID:** NCT00936988
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2005-06
- **Final completion:** 2005-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936988, "A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00936988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*